News
Healthtech company Raremark reboots as XperiomeTM to drive increased value for rare disease patients and researchers
Raremark, the global healthtech company specializing in rare diseases, has announced that it is rebranding as Xperiome™ to better refine and enhance its offering...
News
rfxcel Enters into Acquisition Agreement with Antares Vision Group
rfxcel, a global leader in digital supply chain traceability solutions, announced that it had entered into an acquisition agreement with Italy’s Antares Vision Group,...
News
Russia grants approval to third Covid-19 vaccine for domestic use
Russia has granted approval to its third Covid-19 vaccine for domestic use, with large-scale clinical trials yet to begin. Produced by the Chumakov Centre,...
Clinical Trials
Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the complete enrollment of PREVENT-19, its pivotal Phase 3 study in...
Drug Research
Sanofi to provide manufacturing support to Johnson & Johnson for their COVID-19 vaccine to help address global supply demands
Sanofi has entered into an agreement with Janssen Pharmaceutical NV and Janssen Pharmaceuticals, Inc., two of the Janssen Pharmaceutical Companies of Johnson & Johnson,...
Clinical Trials
Sanofi and GSK initiate new Phase 2 study of their adjuvanted recombinant protein-based COVID-19 vaccine candidate
Sanofi and GSK announced the initiation of a new Phase 2 study with 720 volunteers aged 18 and over to select the most appropriate...
News
Eisai gets Corporate Philanthropy Award for its efforts to realize human health care philosophy
Eisai Co., Ltd. has received the 18th Corporate Philanthropy Award (FY 2020) of the Japan Philanthropic Association. The presentation ceremony was held on last...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read